| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64f645095fc7db1f600c4f465665f256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccebe122bd1f8408395151d9fdc959e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db450e0aa749d71bab191e0cf56af2d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5d20f87f9e57d1a72a8a9e191c58c1f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2014-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60ede7bcb0b3d7fc44802ed8215d913f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fda42af81c6a74b616b8bdcd2de46aec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0f012d891296c0684581c7bee73dd95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fe679d58a33595205587c6e490f464d |
| publicationDate |
2015-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015322074-A1 |
| titleOfInvention |
4-fluoropiperidine orexin receptor antagonists |
| abstract |
The present invention is directed to 4-fluoropiperidine compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015322041-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016068510-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10196383-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9695163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9725434-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9765057-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9643955-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9828368-B2 |
| priorityDate |
2013-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |